An observational study in HIV patients to describe the lipid profile outcome of three different drugs (darunavir, raltegravir and rilpivirine) in a real-life situation.
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Darunavir (Primary) ; Raltegravir (Primary) ; Rilpivirine (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Therapeutic Use
- 02 Jan 2017 New trial record